Publication: Lipoprotein apheresis and proprotein convertase subtilisin/kexin type 9 inhibitors: Do we have a vanquishing new strategy?
| dc.contributor.author | Veljić, Ivana (57203875022) | |
| dc.contributor.author | Polovina, Marija (35273422300) | |
| dc.contributor.author | Milinković, Ivan (51764040100) | |
| dc.contributor.author | Seferović, Petar M (6603594879) | |
| dc.date.accessioned | 2025-06-12T15:13:32Z | |
| dc.date.available | 2025-06-12T15:13:32Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | [No abstract available] | |
| dc.identifier.uri | https://doi.org/10.1177/2047487318817671 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060160273&doi=10.1177%2f2047487318817671&partnerID=40&md5=1a30e535f38844be3773e6b0aea53826 | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/5591 | |
| dc.title | Lipoprotein apheresis and proprotein convertase subtilisin/kexin type 9 inhibitors: Do we have a vanquishing new strategy? | |
| dspace.entity.type | Publication |